Characterization of Mesoamerican Nephropathy in a Kidney Failure Hotspot in Nicaragua

American Journal of Kidney Diseases

Volumn 68, Issue 5, 2016, Pages 716-725

  Kupferman, Joseph ^a   Amador, Juan José ^b   Lynch, Katherine E ^a   Laws, Rebecca L ^b   López Pilarte, Damaris ^b   Ramírez Rubio, Oriana ^b   Kaufman, James S ^c   Lau, Jorge Luis ^d   Weiner, Daniel E ^e   Robles, Ninoska Violeta ^f   Verma, Karina P ^a   Scammell, Madeleine K ^b   McClean, Michael D ^b   Brooks, Daniel R ^b   Friedman, David J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Universidad Nacional Autónoma de Nicaragua   (Nicaragua)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Ministry of Health   (Nicaragua)

Author keywords

Central America; chronic kidney disease (CKD); chronic kidney disease of unknown etiology (CKDu); endemic nephropathy; familial clustering; hyperuricemia; Mesoamerican nephropathy (MeN); NHANES; Nicaragua; uric acid

Indexed keywords

ALBUMIN; ALLOPURINOL; BICARBONATE; CALCIUM; CREATININE; GLUCOSE; MAGNESIUM; PHOSPHORUS; POTASSIUM; SODIUM; URIC ACID;

ADULT; AGED; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; HYPERTENSION; HYPERURICEMIA; HYPOKALEMIA; HYPONATREMIA; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MESOAMERICAN NEPHROPATHY; NICARAGUA; PHENOTYPE; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; RISK FACTOR; SODIUM BLOOD LEVEL; URIC ACID BLOOD LEVEL; VERY ELDERLY; CENTRAL AMERICA; COMPLICATION; MIDDLE AGED; NUTRITION; RENAL INSUFFICIENCY;

ADULT; AGED; CENTRAL AMERICA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; NICARAGUA; NUTRITION SURVEYS; RENAL INSUFFICIENCY;

EID: 84994130146     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.06.012     Document Type: Article

References (58)

1. 1 Correa-Rotter, R., Wesseling, C., Johnson, R.J., CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy. Am J Kidney Dis 63 (2014), 506–520.
2. 2 Weiner, D.E., McClean, M.D., Kaufman, J.S., Brooks, D.R., The Central American epidemic of CKD. Clin J Am Soc Nephrol 8 (2013), 504–511.
3. 3 Wesseling, C., Crowe, J., Hogstedt, C., Jakobsson, K., Lucas, R., Wegman, D., (eds.) Mesoamerican Nephropathy. Report from the First International Research Workshop on MeN, 2012, Central American Institute for Studies on Toxic Substances (IRET-UNA); Program on Work, Environment and Health in Central America (SALTRA), Costa Rica.
4. 4 Wesseling, C., Crowe, J., Hogstedt, C., et al. Resolving the enigma of the Mesoamerican nephropathy: a research workshop summary. Am J Kidney Dis 63 (2014), 396–404.
5. 5 Trabanino, R.G., Aguilar, R., Silva, C.R., Mercado, M.O., Merino, R.L., [End-stage renal disease among patients in a referral hospital in El Salvador]. Rev Panam Salud Publica 12 (2002), 202–206.
6. 6 Ordunez, P., Saenz, C., Martinez, R., Chapman, E., Reveiz, L., Becerra, F., The epidemic of chronic kidney disease in Central America. Lancet Glob Health 2 (2014), e440–e441.
7. 7 Wesseling, C., van Wendel de Joode, B., Crowe, J., et al. Mesoamerican nephropathy: geographical distribution and time trends of chronic kidney disease mortality between 1970 and 2012 in Costa Rica. Occup Environ Med 72 (2015), 714–721.
8. 8 Chronic Kidney Disease in Agricultural Communities in Central America. Concept Paper, 2013, Pan American Health Organization, Washington, DC http://www.paho.org/hq/index.php?option=com_content&view=article&id=8833&Itemid=40033&lang=en. Accessed August 3, 2016.
9. 9 Visualizing Renal Failure and Chronic Kidney Diseases Age-Standardized Mortality Rate in Countries of the Americas, 2000-2009. Non-communicable Diseases and Mental Health, 2014, Pan American Health Organization, Washington, DC http://www.paho.org/hq/index.php?option=com_content&view=article&id=9402. Accessed August 3, 2016.
10. 10 WHO Disease and Injury Country Estimates, Burden of Disease. Death Estimates for 2008 by Cause for WHO Member States, 2011, Department of Measurement and Health Information, World Health Organization, Geneva, Switzerland http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/. Accessed August 3, 2016.
11. 11 Cohen, J., Mesoamerica's mystery killer. Science 344 (2014), 143–147.
12. 12 Ordunez, P., Martinez, R., Reveiz, L., et al. Chronic kidney disease epidemic in Central America: urgent public health action is needed amid causal uncertainty. PLoS Negl Trop Dis, 8, 2014, e3019.
13. 13 Laux, T.S., Barnoya, J., Guerrero, D.R., Rothstein, M., Dialysis enrollment patterns in Guatemala: evidence of the chronic kidney disease of non-traditional causes epidemic in Mesoamerica. BMC Nephrol, 16, 2015, 54.
14. 14 Orantes, C.M., Herrera, R., Almaguer, M., et al. Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009. MEDICC Rev 13 (2011), 14–22.
15. 15 O'Donnell, J.K., Tobey, M., Weiner, D.E., et al. Prevalence of and risk factors for chronic kidney disease in rural Nicaragua. Nephrol Dial Transplant 26 (2011), 2798–2805.
16. 16 Raines, N., Gonzalez, M., Wyatt, C., et al. Risk factors for reduced glomerular filtration rate in a Nicaraguan community affected by Mesoamerican nephropathy. MEDICC Rev 16 (2014), 16–22.
17. 17 Lebov, J.F., Valladares, E., Pena, R., et al. A population-based study of prevalence and risk factors of chronic kidney disease in Leon, Nicaragua. Can J Kidney Health Dis, 2, 2015, 6.
18. 18 Peraza, S., Wesseling, C., Aragon, A., et al. Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis 59 (2012), 531–540.
19. 19 Torres, C., Aragon, A., Gonzalez, M., et al. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis 55 (2010), 485–496.
20. 20 Sanoff, S.L., Callejas, L., Alonso, C.D., et al. Positive association of renal insufficiency with agriculture employment and unregulated alcohol consumption in Nicaragua. Ren Fail 32 (2010), 766–777.
21. 21 Orantes, C.M., Herrera, R., Almaguer, M., et al. Epidemiology of chronic kidney disease in adults of Salvadoran agricultural communities. MEDICC Rev 16 (2014), 23–30.
22. 22 McClean M, Amador JJ, Laws R, et al. Biological Sampling Report: Investigating Biomarkers of Kidney Injury and Chronic Kidney Disease Among Workers in Western Nicaragua. 2012. http://www.cao-ombudsman.org/cases/document-links/documents/Biological_Sampling_Report_April_2012.pdf. Accessed August 3, 2016.
23. 23 Johnson, R.J., Sanchez-Lozada, L.G., Chronic kidney disease: Mesoamerican nephropathy–new clues to the cause. Nat Rev Nephrol 9 (2013), 560–561.
24. 24 Ramirez-Rubio, O., Brooks, D.R., Amador, J.J., Kaufman, J.S., Weiner, D.E., Scammell, M.K., Chronic kidney disease in Nicaragua: a qualitative analysis of semi-structured interviews with physicians and pharmacists. BMC Public Health, 13, 2013, 350.
25. 25 Garcia-Trabanino, R., Jarquin, E., Wesseling, C., et al. Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador–a cross-shift study of workers at risk of Mesoamerican nephropathy. Environ Res 142 (2015), 746–755.
26. 26 Paula Santos, U., Zanetta, D.M., Terra-Filho, M., Burdmann, E.A., Burnt sugarcane harvesting is associated with acute renal dysfunction. Kidney Int 87 (2015), 792–799.
27. 27 Yaqub, F., Kidney disease in farming communities remains a mystery. Lancet 383 (2014), 1794–1795.
28. 28 Laws, R.L., Brooks, D.R., Amador, J.J., et al. Changes in kidney function among Nicaraguan sugarcane workers. Int J Occup Environ Health 21 (2015), 241–250.
29. 29 Herrera, R., Orantes, C.M., Almaguer, M., et al. Clinical characteristics of chronic kidney disease of nontraditional causes in Salvadoran farming communities. MEDICC Rev 16 (2014), 39–48.
30. 30 Wijkström, J., Leiva, R., Elinder, C.G., et al. Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America. Am J Kidney Dis 62 (2013), 908–918.
31. 31 Lopez-Marin, L., Chavez, Y., Garcia, X.A., et al. Histopathology of chronic kidney disease of unknown etiology in Salvadoran agricultural communities. MEDICC Rev 16 (2014), 49–54.
32. 32 Laws, R.L., Brooks, D.R., Amador, J.J., et al. Biomarkers of kidney injury among Nicaraguan sugarcane workers. Am J Kidney Dis 67 (2016), 209–217.
33. 33 Athuraliya, N.T., Abeysekera, T.D., Amerasinghe, P.H., et al. Uncertain etiologies of proteinuric-chronic kidney disease in rural Sri Lanka. Kidney Int 80 (2011), 1212–1221.
34. 34 Nanayakkara, S., Komiya, T., Ratnatunga, N., et al. Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in North Central Province of Sri Lanka. Environ Health Prev Med 17 (2012), 213–221.
35. 35 Wernerson, A., Wijkström, J., Elinder, C.G., Update on endemic nephropathies. Curr Opin Nephrol Hypertens 23 (2014), 232–238.
36. 36 Chatterjee, R., Occupational hazard. Science 352 (2016), 24–27.
37. 37 Herman, J.B., Mount, F.W., Medalie, J.H., et al. Diabetes prevalence and serum uric acid. Diabetes 16 (1967), 858–868.
38. 38 Shichiri, M., Iwamoto, H., Shiigai, T., Diabetic renal hypouricemia. Arch Intern Med 147 (1987), 225–228.
39. 39 Roncal-Jimenez, C., Garcia-Trabanino, R., Barregard, L., et al. Heat stress nephropathy from exercise-induced uric acid crystalluria: a perspective on Mesoamerican nephropathy. Am J Kidney Dis 67 (2016), 20–30.
40. 40 Roncal Jimenez, C.A., Ishimoto, T., Lanaspa, M.A., et al. Fructokinase activity mediates dehydration-induced renal injury. Kidney Int 86 (2014), 294–302.
41. 41 Johnson, R.J., Rodriguez-Iturbe, B., Roncal-Jimenez, C., et al. Hyperosmolarity drives hypertension and CKD–water and salt revisited. Nat Rev Nephrol 10 (2014), 415–420.
42. 42 Johnson, R.J., Nakagawa, T., Jalal, D., Sanchez-Lozada, L.G., Kang, D.H., Ritz, E., Uric acid and chronic kidney disease: which is chasing which?. Nephrol Dial Transplant 28 (2013), 2221–2228.
43. 43 Jalal, D.I., Chonchol, M., Chen, W., Targher, G., Uric acid as a target of therapy in CKD. Am J Kidney Dis 61 (2013), 134–146.
44. 44 Levy, G., Cheetham, T.C., Is it time to start treating asymptomatic hyperuricemia?. Am J Kidney Dis 66 (2015), 933–935.
45. 45 Siu, Y.P., Leung, K.T., Tong, M.K., Kwan, T.H., Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47 (2006), 51–59.
46. 46 Goicoechea, M., de Vinuesa, S.G., Verdalles, U., et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5 (2010), 1388–1393.
47. 47 Goicoechea, M., Garcia de Vinuesa, S., Verdalles, U., et al. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. Am J Kidney Dis 65 (2015), 543–549.
48. 48 Sircar, D., Chatterjee, S., Waikhom, R., et al. Efficacy of febuxostat for slowing the GFR decline in patients with CKD and asymptomatic hyperuricemia: a 6-month, double-blind, randomized, placebo-controlled trial. Am J Kidney Dis 66 (2015), 945–950.
49. 49 Testa, A., Mallamaci, F., Spoto, B., et al. Association of a polymorphism in a gene encoding a urate transporter with CKD progression. Clin J Am Soc Nephrol 9 (2014), 1059–1065.
50. 50 Kleber, M.E., Delgado, G., Grammer, T.B., et al. Uric acid and cardiovascular events: a mendelian randomization study. J Am Soc Nephrol 26 (2015), 2831–2838.
51. 51 Venkatachalam, M.A., Griffin, K.A., Lan, R., Geng, H., Saikumar, P., Bidani, A.K., Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 298 (2010), F1078–F1094.
52. 52 Venkatachalam, M.A., Weinberg, J.M., Kriz, W., Bidani, A.K., Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol 26 (2015), 1765–1776.
53. 53 Chawla, L.S., Eggers, P.W., Star, R.A., Kimmel, P.L., Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371 (2014), 58–66.
54. 54 Hsu, C.Y., Yes, AKI truly leads to CKD. J Am Soc Nephrol 23 (2012), 967–969.
55. 55 Coca, S.G., Singanamala, S., Parikh, C.R., Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81 (2012), 442–448.
56. 56 Bucaloiu, I.D., Kirchner, H.L., Norfolk, E.R., Hartle, J.E. 2nd, Perkins, R.M., Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 81 (2012), 477–485.
57. 57 Askenazi, D.J., Feig, D.I., Graham, N.M., Hui-Stickle, S., Goldstein, S.L., 3-5 Year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 69 (2006), 184–189.
58. 58 Goldstein, S.L., Acute kidney injury in children and its potential consequences in adulthood. Blood Purif 33 (2012), 131–137.